Eli Lilly Soars, Caterpillar Jumps, Royal Caribbean Rises

On this episode of Stock Movers: - Eli Lilly (LLY) surprised Wall Street by raising its annual sales and profit forecast, as demand for obesity medications soared and thousands of patients started taking its new weight-loss pill before advertising for the drug had even begun. Lilly shares jumped 7.3% at the start of regular trading in New York, its largest gain since February and continued to rally during the day. - Caterpillar (CAT)'s shares surged after the company delivered stronger-than-expected quarterly earnings and raised its long-term revenue outlook, supported by fast-growing sales from construction and power generation equipment. Shares rose about 9% in morning trading on Thursday in New York after the US manufacturer said it now expects sales through the end of the decade to grow at a faster clip than it had previously forecast and continued in the green throughout trading. - Royal Caribbean (RCL) shares rose as the company’s outlook for the year suggests it will be able to weather headwinds such as higher fuel costs and disruptions on its Middle Eastern itineraries. The cruise operator cut its full-year adjusted earnings forecast to $17.10 to $17.50 a share, from $17.70 to $18.10 previously, though the midpoint remains above the $17.14 Wall Street consensus. Demand remains resilient, with April bookings exceeding last year and strength in last-minute reservations, the company said in a statement. Bookings for high-yield Mediterranean itineraries have moderated following recent geopolitical developments, partly due to higher airfares, reduced airline capacity and flight disruptions, though recent weeks have shown a rebound.See omnystudio.com/listener for privacy information.